1887

Microbiology Society logo

Volume 149, Issue 11

Biosynthetic specificity of the rhamnosyltransferase gene of serovar 2 as determined by allelic exchange mutagenesis Free

Abstract

In prior studies, through recombinant expression in , the gene of was shown to encode a rhamnosyltransferase that catalyses the addition of rhamnose (Rha) to the 6-deoxytalose of serovar 2-specific glycopeptidolipid (GPL). Whether RtfA also catalyses the transfer of Rha to the alaninol of the lipopeptide core is unknown. An isogenic mutant of serovar 2 strain TMC724 was derived using a novel allelic exchange mutagenesis system utilizing a multicopy plasmid that contained the gene of and the gene encoding green fluorescent protein (). Overexpression of KatG in resulted in increased susceptibility to isoniazid, thus providing counter-selection by enriching for clones that had lost plasmid DNA. Plasmid loss was confirmed by screening for -negative clones to select putative allelic exchange mutants. Two exchange mutants were created, confirmed by Southern hybridization, and demonstrated loss of serovar 2-specific GPL by thin-layer chromatography (TLC). Gas chromatography of alditol acetate derivatives revealed the loss of Rha and the terminal 2,3--Me-fucose and preservation of 3--Me-Rha and 3,4--Me-Rha substituents at the terminal alaninol of the lipopeptide core. Complementation of through an integrative plasmid restored serovar 2-specific GPL expression identical to wild-type TMC724. This result shows that encodes an enzyme responsible only for the transfer of Rha to the serovar 2-specific oligosaccharide and provides a system of allelic exchange for as a tool for future genetic studies involving this species.

  • Received:
  • Accepted:
  • Revised:
  • Published Online:
Keyword(s): 6-dTal, 6-deoxytalose , GPL, glycopeptidolipid , INH, isoniazid , LP, lipopeptide , nsGPL, non-specific glycopeptidolipid , Rha, rhamnose and ssGPL, serovar-specific glycopeptidolipid
SGM
Loading

Article metrics loading...

/content/journal/micro/10.1099/mic.0.26565-0
2003-11-01
2024-04-27
Loading full text...

Full text loading...

/deliver/fulltext/micro/149/11/mic1493193.html?itemId=/content/journal/micro/10.1099/mic.0.26565-0&mimeType=html&fmt=ahah

References

  1. Aldovini A., Husson R. N., Young R. A. 1993; The uraA locus and homologous recombination in Mycobacterium bovis BCG. J Bacteriol 175:7282–7289
     [Google Scholar]
  2. Arbeit R. D., Slutsky A., Barber T. W., Maslow J. N., Niemczyk S., Falkinham J. O. III, O'Conner G. T., von Reyn C. F. 1993; Genetic diversity among strains of Mycobacterium avium causing monoclonal and polyclonal bacteremia in patients with AIDS. J Infect Dis 167:1384–1390
     [Google Scholar]
  3. Aspinall G. O., Chatterjee D., Brennan P. J. 1995; The variable surface glycolipids of mycobacteria: structures, synthesis of epitopes, and biological properties. Adv Carbohydr Chem Biochem 51:169–242
     [Google Scholar]
  4. Balasubramanian V., Pavelka M. S. Jr, Bardarov S. S., Martin J., Weisbrod T. R., McAdam R. A., Bloom B. R., Jacobs W. R. Jr 1996; Allelic exchange in Mycobacterium tuberculosis with long linear recombination substrates. J Bacteriol 178:273–279
     [Google Scholar]
  5. Barrow W. W. 1991; Contributing factors of pathogenesis in the Mycobacterium avium complex. Res Microbiol 142:427–433
     [Google Scholar]
  6. Barrow W. W., Carvalho de Sousa J. P., Davis T. L., Wright E. L., Bachelet M., Rastogi N. 1993; Immunomodulation of human peripheral blood mononuclear cell functions by defined lipid fractions of Mycobacterium avium. Infect Immun 61:5286–5293
     [Google Scholar]
  7. Barrow W. W., Davis T. L., Wright E. L., Labrousse V., Bachelet M., Rastogi N. 1995; Immunomodulatory spectrum of lipids associated with Mycobacterium avium serovar 8. Infect Immun 63:126–133
     [Google Scholar]
  8. Baulard A., Kremer L., Locht C. 1996; Efficient homologous recombination in fast-growing and slow-growing mycobacteria. J Bacteriol 178:3091–3098
     [Google Scholar]
  9. Belisle J. T., Pascopella L., Inamine J. M., Brennan P. J., Jacobs W. R. Jr 1991; Isolation and expression of a gene cluster responsible for biosynthesis of the glycopeptidolipid antigens of Mycobacterium avium. J Bacteriol 173:6991–6997
     [Google Scholar]
  10. Belisle J. T., McNeil M. R., Chatterjee D., Inamine J. M., Brennan P. J. 1993a; Expression of the core lipopeptide of the glycopeptidolipid surface antigens in rough mutants of Mycobacterium avium. J Biol Chem 268:10510–10516
     [Google Scholar]
  11. Belisle J. T., Klaczkiewicz K., Brennan P. J., Jacobs W. R. Jr, Inamine J. M. 1993b; Rough morphological variants of Mycobacterium avium. Characterization of genomic deletions resulting in the loss of glycopeptidolipid expression. J Biol Chem 268:10517–10523
     [Google Scholar]
  12. Brennan P. J. 1988; Mycobacterium and other actinomycetes. In Microbial Lipids pp  203–298 Edited by Ratledge C., Wilkinson S. G. London: Academic Press;
     [Google Scholar]
  13. Brooks R. W., Parker B. C., Gruft H., Falkinham J. O. III 1984; Epidemiology of infection by nontuberculous mycobacteria. V. Numbers in eastern United States soils and correlation with soil characteristics. Am Rev Respir Dis 130:630–633
     [Google Scholar]
  14. Brownback P. E., Barrow W. W. 1988; Modified lymphocyte response to mitogens after intraperitoneal injection of glycopeptidolipid antigens from Mycobacterium avium complex. Infect Immun 56:1044–1050
     [Google Scholar]
  15. Burman W. J., Stone B. L., Reitmeijer C. A., Maslow J., Cohn D. L., Reves R. R. 1998; Long-term outcomes of treatment of Mycobacterium avium complex bacteremia using a clarithromycin-containing regimen. AIDS 12:1309–1315
     [Google Scholar]
  16. Draper P., Rees R. J. W. 1970; Electron-transparent zone of mycobacteria may be a defence mechanism. Nature 228:860–861
     [Google Scholar]
  17. Draper P., Rees R. J. W. 1973; The nature of the electron-transparent zone that surrounds Mycobacterium lepraemurium inside host cells. J Gen Microbiol 77:79–87
     [Google Scholar]
  18. Eckstein T. M., Silbaq F. S., Chatterjee D., Kelly N. J., Brennan P. J., Belisle J. T. 1998; Identification and recombinant expression of a Mycobacterium avium rhamnosyltransferase gene ( rtfA) involved in glycopeptidolipid biosynthesis. J Bacteriol 180:5567–5573
     [Google Scholar]
  19. Gan H., Newman G., McCarthy P. L., Remold H. G. 1993; TNF- α response of human monocyte-derived macrophages to Mycobacterium avium, serovar 4, is of brief duration and protein kinase C dependent. J Immunol 150:2892–2900
     [Google Scholar]
  20. George K. L., Parker B. C., Gruft H., Falkinham J. O. III 1980; Epidemiology of infection by nontuberculous mycobacteria. II. Growth and survival in natural waters. Am Rev Respir Dis 122:89–94
     [Google Scholar]
  21. Havlir D. V., Dubé M. P., Sattler F. R. 9 other authors 1996; Prophylaxis against disseminated Mycobacterium avium complex with weekly azithromycin, daily rifabutin, or both. California Collaborative Treatment Group. N Engl J Med 335:392–398
     [Google Scholar]
  22. Hawkins C. C., Gold J. W., Whimbey E., Kiehn T. E., Brannon P., Cammarata R., Brown A. E., Armstrong D. 1986; Mycobacterium avium complex infections in patients with the acquired immunodeficiency syndrome. Ann Intern Med 105:184–188
     [Google Scholar]
  23. Horgan L., Barrow E. L. W., Barrow W. W., Rastogi N. 2000; Exposure of human peripheral blood mononuclear cells to total lipids and serovar-specific glycopeptidolipids from Mycobacterium avium serovars 4 and 8 results in inhibition of TH1-type responses. Microb Pathog 29:9–16
     [Google Scholar]
  24. Horsburgh C. R. Jr 1991; Mycobacterium avium complex infection in the acquired immunodeficiency syndrome. N Engl J Med 324:1332–1338
     [Google Scholar]
  25. Howard N. S., Gomez J. E., Ko C., Bishai W. R. 1995; Color selection with a hygromycin-resistance-based Escherichia coli–mycobacterial shuttle vector. Gene 166:181–182
     [Google Scholar]
  26. Husson R. N., James B. E., Young R. A. 1990; Gene replacement and expression of foreign DNA in mycobacteria. J Bacteriol 172:519–524
     [Google Scholar]
  27. Lee S. H., Cheung M., Irani V., Carroll J. D., Inamine J. M., Howe W. R., Maslow J. N. 2002; Optimization of electroporation conditions for Mycobacterium avium. Tuberculosis 82:167–174
     [Google Scholar]
  28. Marklund B.-I., Speert D. P., Stokes R. W. 1995; Gene replacement through homologous recombination in Mycobacterium intracellulare. J Bacteriol 177:6100–6105
     [Google Scholar]
  29. Marklund B.-I., Mahenthiraralingam E., Stokes R. W. 1997; Site-directed mutagenesis and virulence assessment of the M. intracellulare katG gene. In Abstracts of the 97th General Meeting of the American Society for Microbiology, abstract U-95 Washington, DC: American Society for Microbiology;
     [Google Scholar]
  30. McNeil M., Tsang A. Y., Brennan P. J. 1987; Structure and antigenicity of the specific oligosaccharide hapten from the glycopeptidolipid antigen of Mycobacterium avium serotype 4, the dominant mycobacterium isolated from patients with acquired immune deficiency syndrome. J Biol Chem 262:2630–2635
     [Google Scholar]
  31. Mdluli K., Swanson J., Fischer L., Lee R. E., Barry C. E. 3rd (1998; Mechanisms involved in the intrinsic isoniazid resistance of Mycobacterium avium. Mol Microbiol 27:1223–1233
     [Google Scholar]
  32. Mills J. A., McNeil M. R., Belisle J. T., Jacobs W. R. Jr, Brennan P. J. 1994; Loci of Mycobacterium avium ser2 gene cluster and their functions. J Bacteriol 176:4803–4808
     [Google Scholar]
  33. Minami H. 1998; Promotion of phagocytosis and prevention of phagosome–lysosome (P–L) fusion in human peripheral blood monocytes by serotype specific glycopeptidolipid (GPL) antigen of Mycobacterium avium complex (MAC. Kekkaku 73:545–556 in Japanese
    [Google Scholar]
  34. Newman G. W., Gan H. X., McCarthy P. L. Jr, Remold H. G. 1991; Survival of human macrophages infected with Mycobacterium avium– intracellulare correlates with increased production of tumor necrosis factor- α and IL-6. J Immunol 147:3942–3948
     [Google Scholar]
  35. Nightingale S. D., Byrd L. T., Southern P. M., Jockusch J. D., Cal S. X., Wynne B. A. 1992; Incidence of Mycobacterium avium– intracellulare complex bacteremia in human immunodeficiency virus-positive patients. J Infect Dis 165:1082–1085
     [Google Scholar]
  36. Norman E., Dellagostin O. A., McFadden J., Dale J. W. 1995; Gene replacement by homologous recombination in Mycobacterium bovis BCG. Mol Microbiol 16:755–760
     [Google Scholar]
  37. Pelicic V., Reyrat J. M., Gicquel B. 1996a; Positive selection of allelic exchange mutants in Mycobacterium bovis BCG. FEMS Microbiol Lett 144:161–166
     [Google Scholar]
  38. Pelicic V., Reyrat J.-M., Gicquel B. 1996b; Expression of the Bacillus subtilis sacB gene confers sucrose sensitivity on mycobacteria. J Bacteriol 178:1197–1199
     [Google Scholar]
  39. Pelicic V., Jackson M., Reyrat J. M., Jacobs W. R. Jr, Gicquel B., Guilhot C. 1997; Efficient allelic exchange and transposon mutagenesis in Mycobacterium tuberculosis. Proc Natl Acad Sci U S A 94:10955–10960
     [Google Scholar]
  40. Pierce M., Crampton S., Henry D. 10 other authors 1996; A randomized trial of clarithromycin as prophylaxis against disseminated Mycobacterium avium complex infection in patients with advanced acquired immunodeficiency syndrome. N Engl J Med 335:384–391
     [Google Scholar]
  41. Sambrook J., Fritsch E. F., Maniatis T. 1989 Molecular Cloning: a Laboratory Manual, 2nd edn. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory;
  42. Sander P., Meier A., Böttger E. C. 1995; rpsL+: a dominant selectable marker for gene replacement in mycobacteria. Mol Microbiol 16:991–1000
     [Google Scholar]
  43. Shafran S. D., Singer J., Zarowny D. P. 9 other authors 1996; A comparison of two regimens for the treatment of Mycobacterium avium complex bacteremia in AIDS: rifabutin, ethambutol, and clarithromycin versus rifampin, ethambutol, clofazimine, and ciprofloxacin. Canadian HIV Trials Network Protocol 010 Study Group. N Engl J Med 335:377–383
     [Google Scholar]
  44. Snapper S. B., Melton R. E., Mustafa S., Kieser T., Jacobs W. R. Jr 1990; Isolation and characterization of efficient plasmid transformation mutants of Mycobacterium smegmatis. Mol Microbiol 4:1911–1919
     [Google Scholar]
  45. Tassell S. K., Pourshafie M., Wright E. L., Richmond M. G., Barrow W. W. 1992; Modified lymphocyte response to mitogens induced by the lipopeptide fragment derived from Mycobacterium avium serovar-specific glycopeptidolipids. Infect Immun 60:706–711
     [Google Scholar]
  46. von Reyn C. F., Waddell R. D., Eaton T. 10 other authors 1993; Isolation of Mycobacterium avium complex from water in the United States, Finland, Zaire, and Kenya. J Clin Microbiol 31:3227–3230
     [Google Scholar]
  47. von Reyn C. F., Maslow J. N., Barber T. W., Falkinham J. O. III, Arbeit R. D. 1994; Persistent colonization of potable water as a source of Mycobacterium avium infection in AIDS. Lancet 343:1137–1141
     [Google Scholar]
  48. Wards B. J., De Lisle G. W., Collins D. M. 2000; An esat6 knockout mutant of Mycobacterium bovis produced by homologous recombination will contribute to the development of a live tuberculosis vaccine. Tuber Lung Dis 80:185–189
     [Google Scholar]
  49. Zhang Y., Heym B., Allen B., Young D., Cole S. 1992; The catalase-peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis. Nature 358:591–593
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/micro/10.1099/mic.0.26565-0
Loading
Biosynthetic specificity of the rhamnosyltransferase gene of Mycobacterium avium serovar 2 as determined by allelic exchange mutagenesis
Microbiology 149, 3193 (2003); https://doi.org/10.1099/mic.0.26565-0
/content/journal/micro/10.1099/mic.0.26565-0
/content/journal/micro/10.1099/mic.0.26565-0
Loading

Data & Media loading...

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error